Mulmit

PUMA BIOTECHNOLOGY, INC.PUMA BIOTECHNOLOGY, INC.

PBYI Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-31228,371,00037,299,00031,111,0000.61
2024-12-31230,468,00030,966,00030,278,0000.62
2023-12-31235,637,00032,640,00021,591,0000.45
2022-12-31228,031,00023,720,0002,0000
2021-12-31253,155,0001,290,00029,126,000-0.72

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-07-06AUERBACH ALAN HPresident and CEO44,058
2026-07-06HUNT DOUGLAS MSee Remarks8,460
2026-07-06NOUGUES MAXIMO FChief Financial Officer9,386
2026-06-12WILSON TROY EDWARD10,800
2026-06-12Stuglik Brian M8,100
2026-06-12Senderowicz Adrian27,000
2026-06-12MOYES JAY M22,000
2026-06-12Dorval Allison11,610
2026-06-11WILSON TROY EDWARD27,000
2026-06-11Stuglik Brian M27,000
2026-06-11Senderowicz Adrian27,000
2026-06-11MILLER MICHAEL PATRICK27,000

8-K events

FiledItems
2026-08-06Results of operations · Financial statements and exhibits
2026-06-16Submission of matters to a vote
2026-05-07Results of operations · Financial statements and exhibits
2026-02-26Results of operations · Financial statements and exhibits
2025-11-06Results of operations · Financial statements and exhibits
2025-08-07Results of operations · Financial statements and exhibits
2025-06-24Amendments to charter or bylaws · Financial statements and exhibits
2025-06-13Submission of matters to a vote
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.